Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI)
| Status: | Recruiting |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 7/5/2018 |
| Start Date: | February 28, 2017 |
| End Date: | January 31, 2019 |
| Contact: | Christopher T Garnett, BA |
| Email: | GarnettC@hss.edu |
| Phone: | 212-774-7022 |
Analgesia After Total Knee Arthroplasty: Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI). A Double-Blinded Randomized Controlled Trial
A comparison of two pain control methods - the combination of Adductor Canal Block
(ACB)/Periarticular Injection (PAI)/Infiltration of the interspace between the popliteal
artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)
- in patients undergoing total knee arthroplasty. Primary outcome is NRS pain scores with
ambulation on postoperative day one (24 hours post-block administration).
(ACB)/Periarticular Injection (PAI)/Infiltration of the interspace between the popliteal
artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)
- in patients undergoing total knee arthroplasty. Primary outcome is NRS pain scores with
ambulation on postoperative day one (24 hours post-block administration).
Inclusion Criteria:
- Patients with osteoarthritis scheduled for a primary either partial or total knee
arthroplasty with a participating surgeon
- Age 18 to 80 years
- Planned use of regional anesthesia
- Ability to follow study protocol
- English speaking (secondary outcomes include questionnaires validated in English only)
- Patients of participating surgeons
Exclusion Criteria:
- Hepatic or renal insufficiency
- Younger than 18 years old and older than 80
- Patients undergoing general anesthesia
- Allergy or intolerance to one of the study medications
- BMI > 40
- Diabetes
- ASA of IV
- Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
- Chronic opioid use (taking opioids for longer than 3 months, or daily oral morphine
equivalent of >5mg/day for one month)
- Patients with severe valgus deformity and flexion contracture
We found this trial at
1
site
Hospital for Special Surgery Founded in 1863, Hospital for Special Surgery is the nation
Click here to add this to my saved trials
